Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: PROPHARMA GROUP LLC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2022-03-02 to 2024-09-06
Current total value of award: $7736500
Description: REVIEW OF LABORATORY-DEVELOPED TESTS (LDTS) AND IN VITRO DIAGNOSTICS (IVDS) SUPPORT TO #1